IBA Expands X-Ray Irradiation Market with Low-Power Rhodotron® LITE
Event summary
- IBA launched Rhodotron® LITE, a low-power X-ray accelerator, on May 20, 2026.
- The system targets small to medium throughput, competing with gamma irradiation centers processing 10,000–20,000 pallets annually.
- Designed for medical device sterilization and food irradiation, it operates at 5 and 7 MeV to meet varying regulations.
- Aims to address global cobalt-60 supply constraints by offering a flexible, on-site alternative.
The big picture
IBA’s Rhodotron® LITE launch targets a critical gap in the irradiation market, where cobalt-60 supply constraints and sustainability demands are reshaping the industry. By offering a scalable X-ray alternative, IBA positions itself to capture demand from both new entrants and existing gamma irradiation users seeking operational flexibility and long-term cost control. The move aligns with broader trends toward decentralized, resilient supply chains in medical and food processing sectors.
What we're watching
- Market Adoption
- Whether small irradiation centers and medical device manufacturers will transition from cobalt-60 to X-ray technology.
- Regulatory Alignment
- How global market regulations will influence the adoption of Rhodotron® LITE’s flexible beam-energy design.
- Competitive Response
- The pace at which competitors will introduce similar low-power X-ray solutions to capture market share.
Related topics